Harvard Bioscience Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Harvard Bioscience, Inc. (HBIO)

0.56 +0.02 (+2.98%) USD | NASDAQ | Feb 12, 16:00

0.554 -0.01 (-1.07%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for HBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	Upgrade
Agenus, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Savara, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	Upgrade